Diamond, Benjamin
University of Miami · Sylvester Comprehensive Cancer Center
10 papers on CoChatORCID 0000-0002-8638-9365
Most cited papers
- Verified
Genomic Classification and Individualized Prognosis in Multiple Myeloma
Maura, F., Rajanna, A. R., Ziccheddu, B., Poos, A. M., Derkach, A., Maclachlan, K., Durante, M., Diamond, B., Papadimitriou, M., Davies, F., et al. (2024) · Journal of Clinical Oncology
Multiple Myeloma Research and TreatmentsLymphoma Diagnosis and Treatment
Cited by 131
- Verified
Whole-genome sequencing reveals progressive versus stable myeloma precursor conditions as two distinct entities
Oben, B., Froyen, G., Maclachlan, K. H., Leongamornlert, D., Abascal, F., Zheng-Lin, B., Yellapantula, V., Derkach, A., Geerdens, E., Diamond, B. T., et al. (2021) · Nature Communications
Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics
Cited by 129
- Verified
Role of AID in the temporal pattern of acquisition of driver mutations in multiple myeloma
Maura, F., Rustad, E. H., Yellapantula, V., Łuksza, M., Hoyos, D., Maclachlan, K. H., Diamond, B. T., Greenbaum, B. D., Morgan, G., Lesokhin, A., et al. (2020) · Leukemia
Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research
Cited by 50
- Verified
Copy number signatures predict chromothripsis and clinical outcomes in newly diagnosed multiple myeloma
Maclachlan, K. H., Rustad, E. H., Derkach, A., Zheng-Lin, B., Yellapantula, V., Diamond, B., Hultcrantz, M., Ziccheddu, B., Boyle, E. M., Blaney, P., et al. (2021) · Nature Communications
Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics
Cited by 49
- Verified
Genomics define malignant transformation in myeloma precursor conditions
Maura, F., Bergsagel, P. L., Ziccheddu, B., Kumar, S., Maclachlan, K., Derkach, A., Garces, J.-J., Firestone, R., Braggio, E., Asmann, Y., et al. (2026) · Journal of Clinical Oncology
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 18
- Verified
Genomic profiling to contextualize the results of intervention for smoldering multiple myeloma
Kazandjian, D., Diamond, B., Papadimitriou, M., Hill, E., Sklavenitis-Pistofidis, R., Ziccheddu, B., Blaney, P., Chojnacka, M., Durante, M., Maclachlan, K., et al. (2024) · Clinical Cancer Research
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia Research
Cited by 16
- Verified
The biological and clinical impact of deletions before and after large chromosomal gains in multiple myeloma
Cirrincione, A. M., Poos, A. M., Ziccheddu, B., Kaddoura, M., Bärtsch, M.-A., Maclachlan, K., Chojnacka, M., Diamond, B., John, L., Reichert, P., et al. (2024) · Blood
Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research
Cited by 15
- Verified
Temporal genomic dynamics shape clinical trajectory in multiple myeloma
Maura, F., Kaddoura, M., Poos, A. M., Baughn, L. B., Ziccheddu, B., Bärtsch, M.-A., Cirrincione, A., Maclachlan, K., Chojnacka, M., Diamond, B., et al. (2025) · Nature Genetics
Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics
Cited by 14
- Verified
Initial whole-genome sequencing of plasma cell neoplasms in first responders and recovery workers exposed to the World Trade Center attack of September 11, 2001
Maura, F., Diamond, B., Maclachlan, K. H., Derkach, A., Yellapantula, V. D., Rustad, E. H., Hultcrantz, M., Shah, U. A., Hong, J., Landau, H. J., et al. (2021) · Clinical Cancer Research
Multiple Myeloma Research and TreatmentsCancer Genomics and Diagnostics
Cited by 10
- Verified
Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy
Magrangeas, F., Cherkaoui, M., Bessonneau-Gaborit, V., Derrien, J., Chevalier, C., Guérin-Charbonnel, C., Diamond, B., Samur, M. K., (IFM), I. F. D. M., Hulin, C., et al. (2026) · Nature Medicine
Multiple Myeloma Research and TreatmentsAcute Myeloid Leukemia Research
Cited by 0
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free